Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-27

Clinical Trial Update: A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating temsirolimus with etoposide and cyclophosphamide in children with relapsed acute lymphoblastic leukemia and non-Hodgkins lymphoma; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Etoposide (Etoposide)
  • Temsirolimus (temsirolimus)

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2023-07-27